A recently published study conducted by Yang et al. [170] has demonstrated that lncRNA FGF14-AS2, which is an anti-sense transcript for FGF14, is significantly downregulated in breast cancer tissue compared with adjacent normal tissue. This evidence concerns the gene FGF14 and breast cancer.